Witnessesreturn to top
Panel I
- Dr. Janet Woodcock , Director, Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, Silver Spring, MD
Panel II
- Carmen S. Catizone , Executive Director, National Association of Boards of Pharmacy, Mount Prospect, IL
- Allan Coukell , Director, Medical Programs, The Pew Charitable Trusts, Washington, DC
- David G. Miller , Executive Vice President and CEO, International Academy of Compounding Pharmacy, Missouri City, TX
- Dr. Kasey K. Thompson , Vice President, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, MD